Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reliv offers distributor incentives

This article was originally published in The Tan Sheet

Executive Summary

With first-quarter net sales down 15.9 percent to $23.8 million, the Chesterfield, Mo.-based firm is trying to spur distributor enrollment by offering sales kits at half price through August. Reliv International said the offer launched in January has produced moderate results with 8,400 distributors enrolled during the quarter, compared to 7,030 in the same period of 2008. Still, total distributors for the multilevel marketer of nutritional products declined 1.5 percent to 68,680 in the January-March period. Chief Financial Officer Steve Albright said during an April 30 earnings call that the recession and the corresponding decline in credit led to smaller initial orders from distributors. Albright added that higher ingredient and packaging costs "may remain a bit of a challenge for much of the year." Reliv's quarterly net income fell to $1 million from $1.5 million in the year-ago period

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102953

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel